Australia markets closed

Lumos Diagnostics Holdings Limited (LDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0570-0.0010 (-1.72%)
At close: 04:10PM AEST
Full screen
Previous close0.0580
Open0.0580
Bid0.0560 x N/A
Ask0.0580 x N/A
Day's range0.0560 - 0.0590
52-week range0.0100 - 0.1750
Volume2,481,838
Avg. volume3,107,663
Market cap27.434M
Beta (5Y monthly)0.67
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • PR Newswire

    Lumos Receives US FDA Clearance for FebriDx®

    Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clearance from the US Food and Drug Administration (FDA) to market its FebriDx® rapid, point-of-care test in the United States.